Suchergebnisse - "Rejeski, Kai"

PubPharm (5)

1

Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy

enthalten in: Annals of hematology | 2024

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

2

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy

enthalten in: Cytotherapy | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

3

Staging of lymphoma under chimeric antigen receptor T-cell therapy : reasons for discordance among imaging response criteria

enthalten in: Cancer imaging : the official publication of the International Cancer Imaging Society | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

4

Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria

enthalten in: Cancer imaging | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

5

Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment : RECIL vs. Lugano vs. metabolic tumor assessment

enthalten in: Frontiers in oncology | 2022

von Winkelmann, M. | Bücklein, V. | Blumenberg, V. | +10

1
[1]